Yahoo Finance

Petros Pharmaceuticals Announces Positive Outcomes in Label Comprehension Study for Potential OTC STENDRA Label

NEW YORK, NY / ACCESSWIRE / October 4, 2023 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over the counter (OTC) nonprescription ...
Yahoo Finance

Petros Pharmaceuticals Announces Positive Results of Over-the-Counter (OTC) Label Comprehension Study for Erectile Dysfunction Drug STENDRA (avanafil)

NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today provides positive ...
Stockhouse

Petros Pharmaceuticals Completes Pilot Label Comprehension Study to Initiate Process for Stendra® Prescription Erectile Dysfunction Medication to Achieve Designation as an ...

NEW YORK, July 13, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI) ("Petros," or "the Company"), a leading provider of therapeutics for men's health, today announced it has completed ...
PharmTech

FDA Issues Draft Guidance on Label Comprehension Studies and Calls for Revision to OTC Labels

The US Food and Drug Administration issued a draft guidance for industry, Label Comprehension Studies for Nonprescription Drug Products, in the May 1 Federal Register. The draft guidance incorporates ...
dailyfreeman.com

Petros Pharmaceuticals Completes Pilot Label Comprehension Study to Initiate Process for Stendra(R) Prescription Erectile Dysfunction Medication to Achieve Designation as an ...

NEW YORK, July 13, 2021 /PRNewswire/ — Petros Pharmaceuticals, Inc. (Nasdaq: PTPI) (“Petros,” or “the Company”), a leading provider of therapeutics for men’s health, today announced it has completed a ...